Kronos Bio Inc (KRON)

May 02, 2025

KRON Shares Experience Decline in Value - knoxdaily.com

May 02, 2025

May 02, 2025

why Kronos Bio Inc [KRON] is a Good Choice for Investors After New Price Target of $1.00 - dbtnews.com

May 02, 2025

May 02, 2025

Kronos shares slump on Concentra takeover news - The Pharma Letter

May 02, 2025

May 01, 2025

Kronos Bio (KRON) to Merge with Concentra Biosciences in $0.57 P - GuruFocus

May 01, 2025

May 01, 2025

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Kronos Bio, Inc.KRON - PR Newswire

May 01, 2025

May 01, 2025

Struggling Peninsula biotech with Gilead lineage is latest purchase for activist investor - The Business Journals

May 01, 2025

May 01, 2025

Now Is The Time To Build A Position In Kronos Bio Inc (NASDAQ:KRON) - Marketing Sentinel

May 01, 2025

May 01, 2025

KRON’s Stock Market Labyrinth: Navigating 2023’s Gains and Declines - investchronicle.com

May 01, 2025

May 01, 2025

Kronos Bio Enters Deal to be Acquired by Concentra Biosciences; Shares Fall - marketscreener.com

May 01, 2025

May 01, 2025

Today’s watch list includes Kronos Bio Inc (NASDAQ:KRON) stock - uspostnews.com

May 01, 2025

May 01, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (NasdaqKRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancor - Morningstar

May 01, 2025

May 01, 2025

Kronos Bio stock hits 52-week low at $0.68 amid market challenges - Investing.com India

May 01, 2025

May 01, 2025

After hunt for alternatives, Kronos Bio selects Tang Capital’s Concentra for a deal - Endpoints News

May 01, 2025

May 01, 2025

Kronos Bio (KRON) to be Acquired by Concentra Biosciences in Strategic Merger | KRON Stock News - GuruFocus

May 01, 2025

May 01, 2025

Shareholder Alert: The Ademi Firm Investigates Whether Kronos Bio, Inc. is Obtaining a Fair Price for Its Public Shareholders - The Joplin Globe

May 01, 2025

May 01, 2025

The Ademi Firm Investigates Whether Kronos Bio, Inc. is Obtaining a Fair Price for Its Public Shareholders - FinancialContent

May 01, 2025

May 01, 2025

KRON Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Kronos Bio, Inc. Is Fair to Shareholders - The Joplin Globe

May 01, 2025

May 01, 2025

Concentra To Acquire Kronos Bio - Nasdaq

May 01, 2025

May 01, 2025

Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right - The Manila Times

May 01, 2025

May 01, 2025

Kronos Bio agrees to Concentra Biosciences acquisition - Investing.com

May 01, 2025

May 01, 2025

Kronos Bio Enters into Agreement to Be Acquired by - GlobeNewswire

May 01, 2025

May 01, 2025

Kronos Bio (KRON) Projected to Announce Quarterly Earnings on Thursday - Defense World

May 01, 2025

Apr 30, 2025

Renaissance Technologies LLC Has $1.11 Million Position in Kronos Bio, Inc. (NASDAQ:KRON) - Defense World

Apr 30, 2025

Apr 11, 2025

Kronos Bio ends lease early, pays $1.4 million settlement - Investing.com Australia

Apr 11, 2025

Apr 10, 2025

Kronos Bio ends lease early, pays $1.4 million settlement By Investing.com - Investing.com Canada

Apr 10, 2025

Apr 10, 2025

Kronos Bio Announces Lease Termination Agreement - TipRanks

Apr 10, 2025

Apr 10, 2025

Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors - The Manila Times

Apr 10, 2025

Mar 28, 2025

Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace

Mar 28, 2025

Mar 26, 2025

Kronos Bio Reports 2024 Financial Results - TipRanks

Mar 26, 2025

Mar 25, 2025

Non-Hodgkin’s Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Mar 25, 2025

Mar 20, 2025

Kronos Bio Full Year 2024 Earnings: US$1.43 loss per share (vs US$1.95 loss in FY 2023) - Yahoo Finance

Mar 20, 2025

Mar 18, 2025

Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Mar 18, 2025

Mar 18, 2025

Kronos Bio earnings missed by $0.17, revenue fell short of estimates - Investing.com Canada

Mar 18, 2025

Mar 18, 2025

Kronos Bio Inc (KRON) Q4 2024 Earnings: EPS Misses at -$0.43, Re - GuruFocus.com

Mar 18, 2025

Mar 18, 2025

Kronos Bio, Inc. SEC 10-K Report - TradingView

Mar 18, 2025

Mar 18, 2025

China Revives Its Carbon Credit Market: Price Swings & Future Outlook - The Globe and Mail

Mar 18, 2025

Mar 18, 2025

Navigating the U.S. Planting Season with Enhanced Risk Management - The Globe and Mail

Mar 18, 2025

Mar 18, 2025

Shootin' the Bull about cattle feeders - The Globe and Mail

Mar 18, 2025

Mar 17, 2025

KRONOS BIO Earnings Preview: Recent $KRON Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 17, 2025

Mar 13, 2025

Kronos Bio (KRON) to Release Quarterly Earnings on Thursday - Defense World

Mar 13, 2025

Mar 11, 2025

Shareholder Alert: The Ademi Firm investigates whether 2seventy bio, Inc. is obtaining a Fair Price for its Public Shareholders - Business Wire

Mar 11, 2025

Feb 23, 2025

Kronos Bio Insider Ups Holding By 36% During Year - Yahoo Finance

Feb 23, 2025

Feb 21, 2025

Shareholder Alert: Ademi LLP investigates whether bluebird bio, Inc. is obtaining a Fair Price for its Public Shareholders - Business Wire

Feb 21, 2025

Feb 17, 2025

Kronos Bio, Inc. (NASDAQ:KRON) Shares Sold by Partners Capital Investment Group LLP - MarketBeat

Feb 17, 2025

Feb 16, 2025

Peapod Lane Capital LLC Purchases New Position in Kronos Bio, Inc. (NASDAQ:KRON) - MarketBeat

Feb 16, 2025

Jan 20, 2025

Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up - MSN

Jan 20, 2025

Jan 19, 2025

Short Interest in Kronos Bio, Inc. (NASDAQ:KRON) Increases By 16.5% - MarketBeat

Jan 19, 2025